Is low bone mass prevalent in male-to-female transsexual persons before the start of cross-sex hormonal therapy and gonadectomy?
Transsexual women before the start of hormonal therapy appear to have lower muscle mass and strength and lower bone mass compared with control men. These baseline differences in bone mass might be related to a less active lifestyle.
Development of type B fulminant hepatitis may be associated with a highly mutated hepatitis B virus strain.